IE880648L - Optically active oxo-isoindolinyl derivatives. - Google Patents

Optically active oxo-isoindolinyl derivatives.

Info

Publication number
IE880648L
IE880648L IE880648A IE64888A IE880648L IE 880648 L IE880648 L IE 880648L IE 880648 A IE880648 A IE 880648A IE 64888 A IE64888 A IE 64888A IE 880648 L IE880648 L IE 880648L
Authority
IE
Ireland
Prior art keywords
optically active
compound
alkyl
formula
image
Prior art date
Application number
IE880648A
Other versions
IE60565B1 (en
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IE880648L publication Critical patent/IE880648L/en
Publication of IE60565B1 publication Critical patent/IE60565B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Optically active oxo-isoindolinyl compounds of formula (I> <IMAGE> wherein R is C1-C4 alkyl; and R1 is hydrogen, C1-C4 alkyl or <IMAGE> wherein n is 1 or 2 and each of R2 and R3, which may be the same or different, is hydrogen or C1-C4 alkyl, or physiologically acceptable salts thereof, are prepared by resolving a racemic compound of formula (II): <IMAGE> into its optical isomers, to give an optically active compound of formula (II) as such or as a salt; reacting the said compound or salt with o-phthalic anhydride to give the corresponding optically active phthalimido compound; and reducing the optically active phthalimido compound. The product obtained can be esterified or salified as desired. The resultant optically active compounds, in particular that in which R is ethyl, exhibit platelet aggregation inhibiting activity. [DE3807595A1]
IE64888A 1987-03-10 1988-08-07 Optically active oxo-isoindolinyl derivatives IE60565B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878705601A GB8705601D0 (en) 1987-03-10 1987-03-10 Oxo-isoindolinyl derivatives

Publications (2)

Publication Number Publication Date
IE880648L true IE880648L (en) 1988-09-10
IE60565B1 IE60565B1 (en) 1994-07-27

Family

ID=10613660

Family Applications (1)

Application Number Title Priority Date Filing Date
IE64888A IE60565B1 (en) 1987-03-10 1988-08-07 Optically active oxo-isoindolinyl derivatives

Country Status (29)

Country Link
JP (1) JPH0759555B2 (en)
KR (1) KR880011096A (en)
CN (1) CN1017527B (en)
AT (1) AT392068B (en)
AU (1) AU605253B2 (en)
BE (1) BE1003280A3 (en)
CH (1) CH675419A5 (en)
DE (1) DE3807595A1 (en)
DK (1) DK168568B1 (en)
ES (1) ES2006361A6 (en)
FI (1) FI93725C (en)
FR (1) FR2612185B1 (en)
GB (2) GB8705601D0 (en)
GR (1) GR1000515B (en)
HU (1) HU201011B (en)
IE (1) IE60565B1 (en)
IL (1) IL85651A (en)
IT (1) IT1227787B (en)
MY (1) MY103898A (en)
NL (1) NL8800575A (en)
NO (1) NO174666C (en)
NZ (1) NZ223805A (en)
PH (1) PH26254A (en)
PT (1) PT86933B (en)
SE (1) SE500710C2 (en)
SU (1) SU1731046A3 (en)
UA (1) UA12840A1 (en)
YU (1) YU46565B (en)
ZA (1) ZA881686B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
IT1256450B (en) * 1992-11-26 1995-12-05 Soldato Piero Del NITRIC ESTERS WITH PHARMACOLOGICAL ACTIVITY AND PROCEDURE FOR THEIR PREPARATION
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
CN100400633C (en) * 2006-03-30 2008-07-09 中国日用化学工业研究院 Detergent for washing dishware with hand and its preparation method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154525A1 (en) * 1970-11-05 1972-06-15 Carlo Erba S.P.A., Mailand (Italien) Isoindoline derivatives and processes for their preparation
GB1344663A (en) * 1970-11-10 1974-01-23 Erba Carlo Spa Isoindoline compounds
US4010274A (en) 1973-07-27 1977-03-01 Carlo Erba Isoindoline derivatives having platelet anti-aggregating activity
JPS516959A (en) * 1974-07-04 1976-01-20 Wakamoto Pharma Co Ltd Isoindorinjudotaino seizohoho
US4400520A (en) * 1980-09-10 1983-08-23 Hisamitsu Pharmaceutical Co., Inc. Novel process for preparing isoindoline derivatives
IT1201408B (en) * 1985-03-22 1989-02-02 Montedison Spa PROCESS FOR THE BIOTECHNOLOGICAL PREPARATION OF OPTICALLY ACTIVE ALFA-ARILALCANOIC ACIDS
JPH07120969B2 (en) * 1989-03-30 1995-12-20 クラリオン株式会社 Spread spectrum modulator

Also Published As

Publication number Publication date
UA12840A1 (en) 1997-02-28
FI93725C (en) 1995-05-26
GB2204579B (en) 1991-01-30
DE3807595A1 (en) 1988-09-22
YU46788A (en) 1990-04-30
NO881055L (en) 1988-09-12
PH26254A (en) 1992-04-01
AU1267988A (en) 1988-09-08
GR1000515B (en) 1992-07-30
IT1227787B (en) 1991-05-07
PT86933B (en) 1992-05-29
FR2612185A1 (en) 1988-09-16
CN1017527B (en) 1992-07-22
NO881055D0 (en) 1988-03-09
PT86933A (en) 1988-04-01
NO174666B (en) 1994-03-07
SE8800846L (en) 1988-09-11
DK168568B1 (en) 1994-04-25
YU46565B (en) 1993-11-16
FI881075A (en) 1988-09-11
SE500710C2 (en) 1994-08-15
NO174666C (en) 1994-06-15
NZ223805A (en) 1990-11-27
DK128988D0 (en) 1988-03-09
CN88101200A (en) 1988-10-26
HUT47247A (en) 1989-02-28
IL85651A0 (en) 1988-08-31
CH675419A5 (en) 1990-09-28
ATA58988A (en) 1990-07-15
IL85651A (en) 1991-07-18
IT8819683A0 (en) 1988-03-08
KR880011096A (en) 1988-10-26
AU605253B2 (en) 1991-01-10
BE1003280A3 (en) 1992-02-18
JPH0759555B2 (en) 1995-06-28
JPS63238058A (en) 1988-10-04
HU201011B (en) 1990-09-28
DK128988A (en) 1988-09-11
ZA881686B (en) 1989-11-29
AT392068B (en) 1991-01-25
MY103898A (en) 1993-10-30
FR2612185B1 (en) 1992-08-28
GB2204579A (en) 1988-11-16
NL8800575A (en) 1988-10-03
SU1731046A3 (en) 1992-04-30
FI881075A0 (en) 1988-03-09
SE8800846D0 (en) 1988-03-09
GB8705601D0 (en) 1987-04-15
GR880100137A (en) 1989-01-31
ES2006361A6 (en) 1989-04-16
GB8805631D0 (en) 1988-04-07
IE60565B1 (en) 1994-07-27
FI93725B (en) 1995-02-15

Similar Documents

Publication Publication Date Title
IE790210L (en) Alkylenediamine derivatives
NO943093L (en) Process for the preparation of clavulanic acid
ES8506677A1 (en) Novel 8-chloro-1,5-benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions.
AU7137591A (en) New derivatives having naphthalene structure, process for preparing these and pharmaceutical compositions containing them
IE781412L (en) Phenylacetic acid derivatives
ES2001341A6 (en) Novel guanidinomethylbenzoic acid derivatives.
GR71716B (en)
CA2013087A1 (en) Carbonate derivatives of eseroline, a process for their preparation and their use as medicaments
IE880648L (en) Optically active oxo-isoindolinyl derivatives.
NO942568L (en) 1-Aryloxy-3-alkylamino-2-propanol nitrate esters, their use and corresponding pharmaceutical composition
ES8106516A1 (en) Process for the preparation of halovincamone derivatives
IE45178L (en) Phenothiazine derivatives
IE820310L (en) 2-amino-3-(halobenzoyl)-methylphenylacetic acid and esters
JPS6466116A (en) Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs
CA2092919A1 (en) Epoxysuccinamic acid derivatives
IE43413L (en) Behenic acid ester
ES8106517A1 (en) 10-halo-E-homoeburnane derivatives, a process for the preparation thereof, a process for the use thereof as vasodilators, and vasodilating compositions thereof
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
IE893258L (en) New 2-carbonyl substituted n,n&#39;-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them
IE862533L (en) Bicyclic catechol derivatives
IE39543B1 (en) Novel cephalosporanic derivatives process for their preparation and compositions incorporating them
ES8106526A1 (en) Process for the preparation of halogenated 15-hydroxy-E-homoeburnane compounds
IT1130997B (en) PHINOXYCARBOXYLIC ACID ESTERS AND KINUCLEIDIN DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
ATE158796T1 (en) PHARMACEUTICALLY ACTIVE ENANTIOMERS
ES8801259A1 (en) Eburnamenine derivatives, pharmaceutical compositions and methods employing them and processes for their preparation

Legal Events

Date Code Title Description
MM4A Patent lapsed